This supports the previous finding that RGS2 decreases global mRNA translation and protein synthesis, cellular stress response, and tumor growth by binding EIF2B3 and disrupting the EIF2-EIF2B GTPase cycle [14,48,49]. The gene discussed is RGS2; the disease is neoplasm.